Analyst RecommendationHe was surprised that the SP has fallen as much as it has. That said, he's still concerned that the sector remains a bit overheated. GLTA
https://www.bnn.ca/video/chris-damas-discusses-cannimed-therapeutics~1122374
CMED-T 2017-05-12 BUY on WEAKNESS Chris Damas
This has a good advantage in that they have already expanded, and have 7000 kg per year capacity of dried bud, whereas others are planning that. They can go from sales level of about a tenth of that, to a higher level very quickly. Pesticides and contaminants are a big issue, and this company has pharmaceutical grade manufacturing at their Saskatoon facility of 97,000 ft.². They also have a facility in Michigan. They’ve been doing this for a long time. He likes medical more than recreational. He would wait for a lower price.
Login to show your approval Login to show your disapproval / Be the first to comment
Price:
$10.020
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
UNKNOWN
Owned:
Unknown